
DNA methylation in Alzheimer’s Disease
DNA methylation as a mechanism, biomarker, and potential therapeutic target for Alzheimer’s disease.
DNA methylation as a mechanism, biomarker, and potential therapeutic target for Alzheimer’s disease.
John McShane recently joined biomodal as our Director of Business Development for Eastern North America and Canada.
Chad Geringer recently joined biomodal and focuses on business development in North America.
Dr Aziz Mustafa recently joined biomodal as our Director of Sales and Business Development for Europe.
We caught up with Aziz to learn more about him, his background, and what excites him about the field of epigenetics.
Two decades ago the Human Genome Project was completed. Since then, the first sequence of the human genome and subsequent population genomes have provided critical
There is more to DNA than the genetic alphabet A, C, G and T. Epigenetics plays a causal role in cell fate, ageing and disease development.
In a recent paper published in Cell, researchers from Harvard Medical School investigated if loss of epigenetic information was a cause of ageing. To do
In this article, we highlight three recent studies that showcase the power of methylation screening for the diagnosis and prognostic measurement of different types of
Learn how simultaneous measurement of genetics and epigenetics with duet multiomics solution +modC enables the study of allele-specific methylation and how this can be used
Review performance of duet multiomics solution +modC for the detection of genetic and epigenetic sequence data at base resolution when using formalin damaged DNA. Samples include formalin-compromised DNA standards (fcDNA) as well as DNA extracted from formalin-fixed and paraffin-embedded (FFPE) samples of two colorectal cancer (CRC) patients.